ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00013520
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : May 21, 2012
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : June 2005
Publications of Results:

Other Publications:
H Ribaudo, D Clifford, R Gulick, C Shikuma, K Klingman, S Snyder, and E Acosta. Relationships between Efavirenz Pharmacokinetics, Side Effects, Drug Discontinuation, Virologic Response, and Race: Results from ACTG A5095/A5097s. CROI 2004. Abstract 132.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):